Very funny. ADO is reeally reeally small and could become...

First 16 Last

Share
Profile

Follow
Stockcount

4,313 Posts.

823

26/04/16

15:17

Post #: 17600315
Share

Originally posted by bullsbears ↑

I haven't checked their Twitter accounts but Twitter is not the definitive link.

Linked in is the only connection that matters (it is like Facebook, but for grown ups) and has proven to be 100% accurate in its predictive capabilities. I have it on good authority that someone that Geoff or Rolf is connected to on linked in, knows someone who's linked to someone who is possibly linked to Steph via someone else on LinkedIn. This is huge.

You just have to follow the bread crumbs and join the dots. Come on ! Do your own research, it's not that hard and you will see that ADO is going to be bigger than Pam Am, Blockbuster and Enron combined!

If ADO didn't work with things that are really really small (in the nano scale) you would realise just how really really big this is.

I was reading an article the other day about how technology is hot. ADO is in technology (or sorts) so it is hot too! Better get some while you can. They are not making anymore ADO shares (until the next share issue or capital raising or financing deal or whatever). With only just over 1 billion shares on issue and with 7.4 billion people in the world - well you do the maths! I'll just wink and say, not everyone can get one.

(Note to self - not for publication - Hope I've pumped this ADO enough that I can get out of this loser)

Expand

Very funny.

ADO is reeally reeally small and could become reeally really big !

Malaria. That is out of left field. Thanks Twin.

If the test is for Malaria and there are millions of tests done, then that is big !

ADO Price at posting: 6.1¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 12 more messages in this thread...

First 16 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $54.77M

Open	High	Low	Value	Volume
2.1¢	2.2¢	2.1¢	$19.27K	914.1K

Buyers (Bids)

No.	Vol.	Price($)
11	1463457	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	1561	1

View Market Depth

No.	Vol.	Price($)
11	1463457	0.020
10	2127381	0.019
5	1657002	0.018
3	1564748	0.017
1	420000	0.016

Price($)	Vol.	No.
0.021	1561	1
0.022	359252	5
0.023	642868	9
0.024	141966	2
0.025	478846	7

Last trade - 13.20pm 07/10/2024 (20 minute delay)

ADO (ASX) Chart

Very funny. ADO is reeally reeally small and could become...

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Very funny. ADO is reeally reeally small and could become...

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News